| Patent application number | Description | Published |
|---|
| 20100011211 | Radio Frequency Identification (RFID) Based Authentication System and Methodology - Disclosed are embodiments of a radio frequency identification (RFID) authentication system and an associated authentication methodology. The embodiments incorporate an identification device (e.g., an identification badge, a key fob, etc.) with an embedded RFID tag. The embedded RFID tag is associated with a specific user and stores a private key generated as part of a public key-private key encryption scheme. The private key is read by an RFID reader and used to decode public key encrypted data stored within or accessible by a computer system (e.g., a desktop computer system, a laptop computer system, a personal digital assistant (PDA), a digital fax machine, wireless telephone, etc.). Thus, the embodiments provide a portable way to use public key-private key encryption scheme data anywhere using RFID technology. | 01-14-2010 |
| 20100011212 | RADIO FREQUENCY IDENTIFICATION (RFID) BASED AUTHENTICATION METHODOLOGY USING STANDARD AND PRIVATE FREQUENCY RFID TAGS - Disclosed is a self-contained hardware-based authentication system that incorporates different authentication protocols for access to soft and/or hard assets with different security levels. The system embodiments include the use of a RFID device that comprises dual RFID tags operating under different frequencies. Specifically, one RFID tag operates on a public frequency and, when activated, transmits an identifier encrypted using a public key. The other RFID tag operates on a private frequency and, when activated, transmits a private key that can be used to decrypt the encrypted identifier. Upon receipt by a processor (e.g., a local processor or security server) of a request for access to a specific asset, a security level for the specific asset is determined. Then, depending upon the particular security level (e.g. low, medium or high) different authentication protocols are instituted using the RFID device. Also disclosed are embodiments of an associated authentication methodology. | 01-14-2010 |
| Patent application number | Description | Published |
|---|
| 20090088702 | METHODS FOR MANUALLY INJECTING/ASPIRATING FLUIDS THROUGH SMALL DIAMETER CATHETERS AND NEEDLES AND MANUAL INJECTION/ASPIRATION SYSTEMS INCLUDING SMALL DIAMETER CATHETERS AND NEEDLES - A system for increasing rates at which fluids may be manually forced through injection/aspiration elements, such as catheters and needles, includes the injection/aspiration elements, as well as a syringe including a pair of crossed handles, one associated with the barrel of the syringe, the other associated with the plunger of the syringe, to provide a mechanical advantage. The system may include and injection/aspiration element of small (e.g., 0.052 inch or smaller) inner diameter. Such systems enable the use of a single hand to hold and operate a syringe in a variety or procedures, including angiography, angioplasty, discography, glue/cement injection, and a variety of aspiration procedures (e.g., biopsy, sampling, media removal, etc.). | 04-02-2009 |
| 20100030098 | LARGE SURFACE AREA TEMPERATURE SENSING DEVICE - A temperature probe for monitoring temperatures of a surface of a tissue or organ within the body of a subject includes a section with a substantially two-dimensional arrangement and a plurality of temperature sensors positioned across an area defined by the substantially two-dimensional arrangement. Such an apparatus may be used in conjunction with procedures in which thermal techniques are used to diagnose a disease state or treat diseased tissue. Specifically, a temperature probe may be used to monitor temperatures across an area of a surface of a tissue or organ located close to the treated tissue to prevent subjection of the monitored tissue or organ to potentially damaging temperatures. | 02-04-2010 |
| 20100100033 | DOUBLE BARREL SYRINGE AND HANDLES FOR USE WITH DOUBLE BARREL SYRINGES - An apparatus that includes two syringes, or a “double barrel syringe,” includes one syringe that injects or infuses while the other syringe aspirates. In the double barrel syringe, injection and aspiration may be effected by a single action. The double barrel syringe may include a handle with two members. A first member of such a handle includes one arm that pivotally couples to a plunger of a first syringe and another arm that pivotally couples to a barrel of a second syringe. A second member of the handle includes one arm that pivotally couples to a barrel of the first syringe and another arm that pivotally couples to a plunger of the second syringe. Methods for injecting or infusing simultaneously with aspirating are also disclosed. | 04-22-2010 |
| 20100249719 | Methods for Manually Injecting/Aspirating Fluids Through Small Diameter Catheters and Needles and Manual Injection/Aspiration Systems Including Small Diameter Catheters and Needles - A system for increasing rates at which fluids may be manually forced through injection/aspiration elements, such as catheters and needles, includes the injection/aspiration elements, as well as a syringe including a pair of crossed handles, one associated with the barrel of the syringe, the other associated with the plunger of the syringe, to provide a mechanical advantage. The system may include and injection/aspiration element of small (e.g., 0.052 inch or smaller) inner diameter and small outer diameter (e.g., 5 French or less). Such systems enable the use of a single hand to hold and operate a syringe in a variety or procedures, including angiography, angioplasty, discography, glue/cement injection, and a variety of aspiration procedures (e.g., biopsy, sampling, media removal, etc.). | 09-30-2010 |
| 20100268116 | SYRINGE WITH ROTATABLE ELEMENT, ASPIRATION SYSTEMS INCLUDING THE SYRINGE, AND ASSOCIATED METHODS - A syringe includes a barrel and a rotatable element on the barrel; for example at a proximal location along the length of the barrel. The rotatable element rotates at least partially around the barrel. When a handle is associated with the rotatable element, the barrel may rotate as the handle is held substantially stationary or the handle may be rotated while the barrel and any peripheral device secured thereto remain substantially stationary. When handles are associated with a rotatable element that may be removed from a barrel, a barrel that is disassembled from the rotatable element may be replaced with another barrel of the same or a different configuration. The barrel and plunger may be configured to cause the barrel to rotate as the plunger moves along the length of the barrel. Methods of using a syringe with a rotatable element on a barrel thereof are also disclosed. | 10-21-2010 |
| 20100274197 | Hinge Assembly for an Injector - A locking hinge assembly for an injector is disclosed. The injector includes a forward handle member, a rear handle member and a hinge connecting the first and second members and defining an axis of rotation. The locking hinge assembly includes a hinge element slidable along the axis of rotation between a locked position and an unlocked position. The hinge element is coupled to the forward handle member and the rear handle member at the hinge, and the hinge element includes at least one groove. Additionally, a locking element is provided and positioned about the hinge. The locking element is configured to be received in the groove such that rotation of the forward handle member and rear handle member about the axis of rotation is prevented when the hinge element is in the locked configuration. | 10-28-2010 |
| Patent application number | Description | Published |
|---|
| 20090123472 | DETECTION OF MUTATIONS IN A GENE ASSOCIATED WITH RESISTANCE TO VIRAL INFECTION, OAS1 - A method for detecting a mutation related to the gene encoding OAS1. This and other disclosed mutations correlate with resistance of humans to viral infection including hepatitis C. Also provided is a therapeutic agent consisting of a protein or polypeptide encoded by the mutated gene, or a polynucleotide encoding the protein or polypeptide. Inhibitors of human OAS1, including antisense oligonucleotides, methods, and compositions specific for human OAS1, are also provided. | 05-14-2009 |
| 20090155234 | DETECTION OF MUTATIONS IN A GENE ASSOCIATED WITH RESISTANCE TO VIRAL INFECTION, MX1 - A method for detecting a mutation related to the gene encoding MxA. This and other disclosed mutations correlate with resistance of humans to viral infection including hepatitis C. Also provided is a therapeutic agent consisting of a protein or polypeptide encoded by the wild-type and mutated genes, or a polynucleotide encoding the protein or polypeptide. Inhibitors of human MxA, including antisense oligonucleotides, methods, and compositions specific for human MxA, are also provided. | 06-18-2009 |
| 20090186028 | Detection of mutations in a gene associated with resistance to viral infection - A method for detecting a mutation related to the gene encoding LDLR. This and other disclosed mutations correlate with resistance of humans to viral infection including hepatitis C. Also provided is a therapeutic agent consisting of a protein or polypeptide encoded by the wild-type and mutated genes, or a polynucleotide encoding the protein or polypeptide. Inhibitors of human LDLR, including antisense oligonucleotides, methods, and compositions specific for human LDLR, are also provided. | 07-23-2009 |
| 20090291074 | MUTATIONS IN OAS1 GENES - Modified amino acid sequences of OAS1 proteins in non-human primates, and genes related thereto, are provided. | 11-26-2009 |
| 20110071073 | Detection of mutations in a gene associated with resistance to viral infection, OAS1 - A method for detecting a mutation related to the gene encoding OAS1. This and other disclosed mutations correlate with resistance of humans to viral infection including hepatitis C. Also provided is a therapeutic agent consisting of a protein or polypeptide encoded by the mutated gene, or a polynucleotide encoding the protein or polypeptide. Inhibitors of human OAS1, including antisense oligonucleotides, methods, and compositions specific for human OAS1, are also provided. | 03-24-2011 |
